维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="ZILEMBO N"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅱ randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first- line treatment of advanced non-small-cell lung cancer in elderly patients显示文摘	Gridelli C Novello S Zilembo N	2014	J Thorac Oncol2014，9，5：	1
2	Aromatase inhibitors in the treatment of postmenopausal breast cancer显示文摘	Bajetta E Zilembo N Bichlsao	1999	Drugs Aging1999，15，4：	1
3	Formestane: effective therapy in postmenopausal women with advanced breast cancer显示文摘	Bajetta E Zilembo N Buzzoni R	1994	Ann Oncol1994，，57：	1
4	Oxaliplatin doublets in non small cell lung cancer: a literature review显示文摘	Cortinovis D Bidoli P Zilembo N	2008	Lung Cancer2008，60，3：	1
5	Steroidal aromatase inhibitors in elderly patients显示文摘	Bajetta E Zilembo N Bichisao E	2000	Crit Rev Oncol Hematol2000，33，2：	1
6	The minimal effective exemestane dose for endocrine activity in advanced breast cancer显示文摘	Zilembo N Noberasco C	1997	Eur J Cancer1997，33，：	1
7	Randomized phaselI three-arm trial with three platinum-based doublets in metastatic non-small-cell lung ancer, an itanlian trials medical oncol study 显示文摘	Bidoli P Zilembo N Cortinovis D	2007	Ann Oncol2007，18，：	1
8	Randomized phase 11 three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer: an Italian trials in medical oncology study 显示文摘	Bidoli P Zilembo N Cortinovis D	2007	~nn Onco12007，18，3：	1
9	Steroidal aromatase inhibitors in early patients 显示文摘	Bajetta E Zilembo N Bichisao E	2000	Crit Rer Oncol hematol2000，33，2：	1
10	Bone turnover markers and insulin-like growth factor components in metastatic breast cancer:results from a randomised trial of exemestane vs megestrol acetate显示文摘	Martinetti A Zilembo N Ferrari L	2003	Anticancer Res2003，23，4：	1
11	Aromatase inhibitors in the treatment ofpostmenopausal breast cancer显示文摘	Bajetta E Zilembo N Bichisao E	1999	Drugs1999，15，4：	1
12	Short-term effects of anastrozole treatment on insulin-lik egrowth factor system in post-menpausal advanced breast cancer patients 显示文摘	Fervari L Martinetti A Zilembo N	2002	Sterioid BiochemMoBiol2002，80，45：	1
13	Activity of formestane in de novo tamoxdfen-resistant patients with metastatic breast cancer显示文摘	Bajetta E Zilembo N	1995	Oncology1995，52，6：	1
14	Randomized phase Ⅱ three-arm trial with three platinum-based dou- blets in metastatic non-small-cell lung cancer: an italiant- dais in medical oncology study显示文摘	Bidoli P Zilembo N Cortinovis D	2007	Ann Oncol2007，18，3：	1
15	Goserelin in premenopausal advanced breast cancer:clinical and endocrine evaluation of responsive patients显示文摘	Bajetta E Zilembo N Buzzoni R	1994	Oncology1994，51，3：	1
16	Randomized phase Ⅱ three-arm trial with three platinum based doublets in metastatic non small cell lung cancer显示文摘	BIDOLI P ZILEMBO N CORTINOV IS D	2007	An Italian Trials in Medical Ontology Study Ann Oncol2007，18，3：	1
17	Formestane: an effective first-line endocrine treatment for advanced breast cancer显示文摘	ZILEMBO N BAJETTA E NOBERASCO C	1995	J Cancer Res Clin Oncol1995，121，6：	1
18	Double-blind, randornisecl, multieantre endocrine trial comparing two letrozole doses, in postm enopausal breast cancer patients显示文摘	Bajetta E Zilembo N Dowsett M etal	1999	Eur J Cancer1999，35，2：	1
19	Goserelin in premenopausal advanced breast cancer: clinical and endocrine evaluation of responsive patients显示文摘	Zilembo N Buzzoni R	1994	Oncology1994，51，3：	1
20	A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse:endocrine and clinical results显示文摘	Zilembo N Barni S	1997	Ann Oncol1997，8，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示